- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04176263
The Effect of Split-belt Treadmill Training on Gait in Parkinson's Disease
August 9, 2021 updated by: Alice Nieuwboer, KU Leuven
The Impact of Split-belt Treadmill Training to Modulate Freezing-related Gait Deficits and Freezing Episodes in Parkinson's Disease
People with Parkinson's disease (PD) often show gait impairments such as, shuffling gait, short steps and gait asymmetry and irregularity.
These gait problems are already apparent in the early disease stages, having an immense effect on daily life functioning.
Especially Freezing of Gait (FOG), where the patients are not able to initiate or continue their movement despite their intention to do so, is a debilitating problem.
It is thought that lack of gait adaptability could be an underlying cause of FOG.
With a split-belt treadmill the speed of both legs can be controlled independently, which forces participants to actively adapt their gait to the new situation.
In a previous study performed at our lab, it was shown that only one session of split-belt training (SBT), in which the speed of one leg was reduced, improved gait adaptability and other gait features compared to tied-belt training (TBT).
Furthermore, overground turning speed improved after only one single training session and this was even retained 24 hours later, indicating training induced long-term potentiation.
Since the short-term effects of SBT are promising, the objective of this study is to investigate if 4 weeks of SBT, 3 times a week, has an effect on gait deficits found in individuals with PD, compared to 4-weeks, 3 times a week, of TBT.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of PD according to the recent criteria of the Movement Disorders Society made by a neurologist
- Participants should be able to walk 5 minutes at a stretch without a walking aid
- Hoehn & Yahr stage II or III in the ON state of medication
- Mini Mental State Examination score of 24 or above
- Participants should have a steady medication schedule at the start of the study (no change in the past month).
- To be included as a freezer participant a score of at least 1 or higher should be recorded with the New Freezing of Gait Questionnaire.
Exclusion Criteria:
- Current enrollment in another clinical study which may interfere with the conduction of this study.
- Orthopedic injuries or other musculoskeletal problems, which could possibly effect balance and/or gait.
- Unable or unwilling to commit to 4 weeks of training, 3 times a week
- Participation in walking training in the month prior to the start of the study
- Other neurological impairments (except PD)
- Cardiovascular exercise risk factors diagnosed by a doctor
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SBT
The SBT group will receive a 4-week split-belt treadmill training program consisting of 3 training sessions every week.
The training will have a progression of training duration over the four weeks.
Participants will start at a total training duration of 30 minutes and this will be increased with 5 minutes every week.
The maximal length will be 45 minutes of training.
One session including breaks will take approximately 1 hour.
|
The SBT group will receive a 4-week split-belt treadmill training, 3 times a week using a standardized progression protocol.
The sessions, including breaks, will approximately take 1 hour each.
The training will be given by a trainer experienced with PD.
|
|
Active Comparator: TBT
The TBT group will receive a 4-week tied-belt treadmill training program consisting of 3 training sessions every week.
The training will have a progression of training duration over the four weeks.
Participants will start at a total training duration of 30 minutes and this will be increased with 5 minutes every week.
The maximal length will be 45 minutes of training.
One session including breaks will take approximately 1 hour.
|
The TBT group will receive a 4-week tied-belt treadmill training, 3 times a week.
To make sure exposure of the two interventions is similar the sessions of the TBT group will be of similar length and progression level (approximately 1 hour each).
The training will be given by a trainer experienced with PD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average overground 360 degree turning speed (degrees/s)
Time Frame: Change in performance between the average overground turning speed from pre to post intervention (i.e. the week after the 4-week training period ended)
|
Participants will be instructed to turn 360 degrees in alternating directions (clockwise/counterclockwise) for 60 seconds.
The instruction is to turn as quickly as possible, while still feeling safe doing this.
The average overground turning speed will be determined by the use of APDM Opal accelerometers which will be worn on both feet, wrists and the lower back.
|
Change in performance between the average overground turning speed from pre to post intervention (i.e. the week after the 4-week training period ended)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average dual task overground 360 degree turning speed (degrees/sec)
Time Frame: Change in performance between the average overground turning speed from pre to post intervention (i.e. the week after the 4-week training period ended)
|
Participants will be instructed to turn 360 degrees in alternating directions (clockwise/counterclockwise) for 60 seconds.
The instruction is to turn as quickly as possible, while still feeling safe doing this.
The average overground turning speed will be determined by the use of APDM Opal accelerometers which will be worn on both feet, wrists and the lower back.
In addition to this task the participants also have to perform an auditory stroop task.
The participant hears the words 'low' and 'high' in either a low or high pitch in random order and timing.
The participant has to respond as quickly as possible to the pitch of the word and not to the word itself.
|
Change in performance between the average overground turning speed from pre to post intervention (i.e. the week after the 4-week training period ended)
|
|
Retention of average overground 360 degree turning speed (degrees/sec)
Time Frame: Change in performance from post-intervention 1 week after the 4-week training period ended (Retest 1) to retention, 5 weeks later (Retest 2).
|
Participants will be instructed to turn 360 degrees in alternating directions (clockwise/counterclockwise) for 60 seconds.
The instruction is to turn as quickly as possible, while still feeling safe doing this.
The average overground turning speed will be determined by the use of APDM Opal accelerometers which will be worn on both feet, wrists and the lower back.
|
Change in performance from post-intervention 1 week after the 4-week training period ended (Retest 1) to retention, 5 weeks later (Retest 2).
|
|
Retention of dual task average overground 360 degree turning speed (degrees/sec)
Time Frame: Change in performance from post-intervention 1 week after the 4-week training period ended (Retest 1) to retention, 5 weeks later (Retest 2).
|
Participants will be instructed to turn 360 degrees in alternating directions (clockwise/counterclockwise) for 60 seconds.
The instruction is to turn as quickly as possible, while still feeling safe doing this.
The average overground turning speed will be determined by the use of APDM Opal accelerometers which will be worn on both feet, wrists and the lower back.
In addition to this task the participants also have to perform an auditory stroop task.
The participant hears the words 'low' and 'high' in either a low or high pitch in random order and timing.
The participant has to respond as quickly as possible to the pitch of the word and not to the word itself.
|
Change in performance from post-intervention 1 week after the 4-week training period ended (Retest 1) to retention, 5 weeks later (Retest 2).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Christian Schlenstedt, PhD, Christian Albrechts University of Kiel
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 12, 2019
Primary Completion (Actual)
May 11, 2021
Study Completion (Actual)
May 11, 2021
Study Registration Dates
First Submitted
November 16, 2019
First Submitted That Met QC Criteria
November 21, 2019
First Posted (Actual)
November 25, 2019
Study Record Updates
Last Update Posted (Actual)
August 10, 2021
Last Update Submitted That Met QC Criteria
August 9, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S62825 (KUL); D454/13 (CAU)
- None was given (Other Grant/Funding Number: Jacques and Gloria Gossweiler Foundation)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on SBT
-
University of Sao Paulo General HospitalCompletedRespiratory FailureBrazil
-
The Miriam HospitalCompletedObesity | Weight LossUnited States
-
Harvard Pilgrim Health CareUniversity of Pennsylvania; Washington University School of Medicine; Duke University and other collaboratorsCompletedVentilator-associated PneumoniaUnited States
-
Centre Hospitalier Régional d'OrléansCompletedMechanical Ventilation | Mechanical Ventilator Weaning | Endotracheal ExtubationFrance
-
Intermountain Health Care, Inc.National Heart, Lung, and Blood Institute (NHLBI); University of UtahRecruitingRespiration, ArtificialUnited States
-
Region SyddanmarkRegion of Southern DenmarkCompletedAttention Deficit/Hyperactivity DisorderDenmark
-
Lora BurkeNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
National Taiwan University HospitalActive, not recruitingVentilator WeaningTaiwan
-
Christiana Care Health ServicesWithdrawnRespiratory Distress Syndrome, Newborn | Ventilator-associated Lung Injury
-
Memorial Medical CenterTerminatedRespiratory InsufficiencyUnited States